Combining immunofluorescence techniques and molecular analyses in vivo and in vitro, the present study provides the first time report on protective roles of miR-132 against diabetic encephalopathy injury by repressing GSK-3β expression and alleviating Tau hyperphosphorylation. This evidence concerns the gene MAPT and diabetic encephalopathy.